Spectral Med Inc (EDT) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Spectral Med Inc (EDT) has a cash flow conversion efficiency ratio of 0.039x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CA$-2.67 Million ≈ $-1.93 Million USD) by net assets (CA$-68.66 Million ≈ $-49.67 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See EDT equity to assets ratio to measure how much of total assets are equity-financed.
Spectral Med Inc - Cash Flow Conversion Efficiency Trend (1992–2024)
This chart illustrates how Spectral Med Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check EDT cash flow quality score to evaluate the quality of earnings relative to operating cash generation.
Spectral Med Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Spectral Med Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Sichuan Haowu Electromechanical Co Ltd
SHE:000757
|
0.020x |
|
Hes Technology Group
SHE:002963
|
0.058x |
|
Austindo Nusantara Jaya Tbk
JK:ANJT
|
-0.022x |
|
Datavault AI Inc.
NASDAQ:DVLT
|
-0.002x |
|
OneIM Acquisition Corp. Class A Ordinary Shares
NASDAQ:OIM
|
-0.002x |
|
Astarta Holding N.V.
WAR:AST
|
0.026x |
|
SUNAC SERVIC.HLDGS HD-01
F:65D
|
N/A |
|
Intracom Holdings S.A.
AT:INTRK
|
-0.008x |
Annual Cash Flow Conversion Efficiency for Spectral Med Inc (1992–2024)
The table below shows the annual cash flow conversion efficiency of Spectral Med Inc from 1992 to 2024. For the full company profile with market capitalisation and key ratios, see market cap of Spectral Med Inc.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | CA$-27.55 Million ≈ $-19.93 Million |
CA$-8.82 Million ≈ $-6.38 Million |
0.320x | -50.58% |
| 2023-12-31 | CA$-16.55 Million ≈ $-11.97 Million |
CA$-10.72 Million ≈ $-7.76 Million |
0.648x | -83.29% |
| 2022-12-31 | CA$-2.55 Million ≈ $-1.85 Million |
CA$-9.90 Million ≈ $-7.16 Million |
3.876x | +281.90% |
| 2021-12-31 | CA$4.08 Million ≈ $2.95 Million |
CA$-8.70 Million ≈ $-6.29 Million |
-2.131x | -540.02% |
| 2020-12-31 | CA$-669.00K ≈ $-483.94K |
CA$-324.00K ≈ $-234.38K |
0.484x | +139.98% |
| 2019-12-31 | CA$2.26 Million ≈ $1.63 Million |
CA$-2.74 Million ≈ $-1.98 Million |
-1.212x | -224.12% |
| 2018-12-31 | CA$6.37 Million ≈ $4.61 Million |
CA$-2.38 Million ≈ $-1.72 Million |
-0.374x | +70.28% |
| 2017-12-31 | CA$2.86 Million ≈ $2.07 Million |
CA$-3.60 Million ≈ $-2.60 Million |
-1.258x | +34.17% |
| 2016-12-31 | CA$5.82 Million ≈ $4.21 Million |
CA$-11.12 Million ≈ $-8.05 Million |
-1.911x | -13.63% |
| 2015-12-31 | CA$5.43 Million ≈ $3.93 Million |
CA$-9.14 Million ≈ $-6.61 Million |
-1.682x | -48.20% |
| 2014-12-31 | CA$8.82 Million ≈ $6.38 Million |
CA$-10.01 Million ≈ $-7.24 Million |
-1.135x | +29.68% |
| 2013-12-31 | CA$5.70 Million ≈ $4.12 Million |
CA$-9.19 Million ≈ $-6.65 Million |
-1.614x | -120.87% |
| 2012-12-31 | CA$10.57 Million ≈ $7.65 Million |
CA$-7.72 Million ≈ $-5.59 Million |
-0.731x | -120.57% |
| 2011-12-31 | CA$18.94 Million ≈ $13.70 Million |
CA$-6.27 Million ≈ $-4.54 Million |
-0.331x | -16.50% |
| 2010-12-31 | CA$15.75 Million ≈ $11.39 Million |
CA$-4.48 Million ≈ $-3.24 Million |
-0.284x | +64.97% |
| 2009-12-31 | CA$1.36 Million ≈ $987.42K |
CA$-1.11 Million ≈ $-801.51K |
-0.812x | -528.74% |
| 2008-12-31 | CA$4.05 Million ≈ $2.93 Million |
CA$-523.00K ≈ $-378.33K |
-0.129x | +4.00% |
| 2007-12-31 | CA$5.44 Million ≈ $3.94 Million |
CA$-732.00K ≈ $-529.52K |
-0.134x | +26.00% |
| 2006-12-31 | CA$6.99 Million ≈ $5.06 Million |
CA$-1.27 Million ≈ $-918.70K |
-0.182x | +96.81% |
| 2005-12-31 | CA$738.00K ≈ $533.86K |
CA$-4.21 Million ≈ $-3.04 Million |
-5.703x | -500.54% |
| 2004-12-31 | CA$5.33 Million ≈ $3.85 Million |
CA$-5.06 Million ≈ $-3.66 Million |
-0.950x | -71.08% |
| 2003-12-31 | CA$9.03 Million ≈ $6.53 Million |
CA$-5.01 Million ≈ $-3.63 Million |
-0.555x | +48.99% |
| 2002-12-31 | CA$3.84 Million ≈ $2.78 Million |
CA$-4.18 Million ≈ $-3.02 Million |
-1.088x | -1548.33% |
| 2001-12-31 | CA$8.19 Million ≈ $5.92 Million |
CA$615.00K ≈ $444.88K |
0.075x | +111.47% |
| 2000-12-31 | CA$5.81 Million ≈ $4.20 Million |
CA$-3.80 Million ≈ $-2.75 Million |
-0.655x | -35.38% |
| 1999-12-31 | CA$9.30 Million ≈ $6.73 Million |
CA$-4.50 Million ≈ $-3.26 Million |
-0.484x | +13.98% |
| 1998-12-31 | CA$16.00 Million ≈ $11.57 Million |
CA$-9.00 Million ≈ $-6.51 Million |
-0.563x | -47.94% |
| 1997-12-31 | CA$26.30 Million ≈ $19.03 Million |
CA$-10.00 Million ≈ $-7.23 Million |
-0.380x | -36.39% |
| 1996-12-31 | CA$39.10 Million ≈ $28.28 Million |
CA$-10.90 Million ≈ $-7.88 Million |
-0.279x | +36.15% |
| 1995-12-31 | CA$28.40 Million ≈ $20.54 Million |
CA$-12.40 Million ≈ $-8.97 Million |
-0.437x | -128.79% |
| 1994-12-31 | CA$39.30 Million ≈ $28.43 Million |
CA$-7.50 Million ≈ $-5.43 Million |
-0.191x | +5.18% |
| 1993-12-31 | CA$15.90 Million ≈ $11.50 Million |
CA$-3.20 Million ≈ $-2.31 Million |
-0.201x | +66.75% |
| 1992-12-31 | CA$3.80 Million ≈ $2.75 Million |
CA$-2.30 Million ≈ $-1.66 Million |
-0.605x | -- |
About Spectral Med Inc
Spectral Medical Inc. focuses on the development and commercialization of products for the treatment of septic shock in the United States, Italy, Ireland, Russia, and internationally. The company markets Endotoxin Activity Assay, a rapid in-vitro diagnostic test for the detection of components of gram negative bacterial cell wall; and Polymyxin B-Hemoperfusion, a therapeutic hemoperfusion device … Read more